Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 0.60%-316.42M | ---- | 23.81%-318.34M | ---- | 22.77%-417.81M | ---- | 66.62%-540.97M | ---- | -293.72%-1.62B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 14.23%-47.39M | ---- | 1.80%-55.25M | ---- | 20.43%-56.26M | ---- | -63.69%-70.7M | ---- | -16.73%-43.19M |
| Interest expense - adjustment | ---- | -19.82%29.81M | ---- | -16.27%37.17M | ---- | 0.97%44.4M | ---- | -15.25%43.97M | ---- | -19.90%51.88M |
| Investment loss (gain) | ---- | -24.01%-1.72M | ---- | 52.45%-1.39M | ---- | 66.54%-2.92M | ---- | 29.90%-8.72M | ---- | 11.49%-12.44M |
| Attributable subsidiary (profit) loss | ---- | 24.39%16.25M | ---- | 71.35%13.07M | ---- | 339.43%7.63M | ---- | -163.18%-3.19M | ---- | -25.71%5.04M |
| Impairment and provisions: | ---- | -87.55%5.78M | ---- | 721.22%46.46M | ---- | -103.17%-7.48M | ---- | 107.55%235.76M | ---- | -2.26%113.59M |
| -Impairment of trade receivables (reversal) | ---- | -133.87%-6.02M | ---- | 162.42%17.76M | ---- | -112.11%-28.45M | ---- | 175.15%234.94M | ---- | 98.34%85.39M |
| -Other impairments and provisions | ---- | -58.88%11.8M | ---- | 36.81%28.69M | ---- | 2,454.69%20.97M | ---- | -97.09%821K | ---- | -61.45%28.21M |
| Revaluation surplus: | ---- | 145.92%73.76M | ---- | -15.12%29.99M | ---- | 766.27%35.34M | ---- | -100.42%-5.3M | ---- | 176.19%1.25B |
| -Fair value of investment properties (increase) | ---- | 118.54%74.93M | ---- | 446.29%34.29M | ---- | 17,062.16%6.28M | ---- | -100.03%-37K | ---- | 1,951.89%140.49M |
| -Other fair value changes | ---- | 72.87%-1.16M | ---- | -114.76%-4.29M | ---- | 651.79%29.06M | ---- | -100.47%-5.27M | ---- | 167.37%1.11B |
| Asset sale loss (gain): | ---- | 14.35%-28.22M | ---- | 62.73%-32.95M | ---- | -1,541.42%-88.41M | ---- | 93.02%-5.39M | ---- | -2,140.77%-77.18M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---3.61M | ---- | ---- | ---- | ---- | ---- | ---70.13M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 119.63%651K | ---- | 74.92%-3.32M | ---- | -1,409.70%-13.23M | ---- | 198.63%1.01M | ---- | -127.08%-1.02M |
| -Loss (gain) from selling other assets | ---- | -10.96%-28.87M | ---- | 65.39%-26.02M | ---- | -1,075.41%-75.18M | ---- | -6.16%-6.4M | ---- | ---6.03M |
| Depreciation and amortization: | ---- | -18.65%256.35M | ---- | -15.82%315.1M | ---- | -5.99%374.32M | ---- | -8.84%398.15M | ---- | -3.20%436.79M |
| -Depreciation | ---- | -18.65%256.35M | ---- | -15.82%315.1M | ---- | --374.32M | ---- | ---- | ---- | ---- |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -59.62%29.02M | ---- | 12.54%71.87M |
| Special items | ---- | 496.84%405.43M | ---- | -90.39%67.93M | ---- | 578.52%706.52M | ---- | 60.68%-147.65M | ---- | -1,881.45%-375.48M |
| Operating profit before the change of operating capital | ---- | 286.66%393.64M | ---- | -82.90%101.81M | ---- | 672.31%595.33M | ---- | 61.34%-104.02M | ---- | -38.19%-269.1M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -77.02%199K | ---- | 1,119.72%866K | ---- | -90.67%71K | ---- | -77.28%761K | ---- | 340.21%3.35M |
| Accounts receivable (increase)decrease | ---- | -112.31%-1.04M | ---- | 8.07%8.42M | ---- | 304.41%7.79M | ---- | -91.98%1.93M | ---- | -45.18%24.03M |
| Accounts payable increase (decrease) | ---- | 116.79%23.85M | ---- | 63.75%-142.08M | ---- | -2,120.11%-391.94M | ---- | 96.01%-17.65M | ---- | -305.10%-442.33M |
| Special items for working capital changes | ---- | -612.16%-76.82M | ---- | -111.49%-10.79M | ---- | 309.28%93.91M | ---- | -0.19%-44.87M | ---- | 67.46%-44.79M |
| Cash from business operations | -995.22%-98.83M | 913.44%339.83M | 79.32%-9.02M | -113.69%-41.78M | 52.58%-43.64M | 286.23%305.16M | 28.03%-92.03M | 77.52%-163.86M | 70.40%-127.86M | -83.59%-728.83M |
| Hong Kong profits tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 6,901.35%5.18M | 12,536.59%5.18M | -98.90%74K |
| China income tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---23.59M | ---- | ---- | ---- |
| Other taxs | 66.94%-3M | 68.44%-6.47M | 54.42%-9.08M | 16.88%-20.49M | ---19.92M | 46.26%-24.65M | ---- | -1,082.39%-45.87M | -415.71%-16.87M | 79.24%-3.88M |
| Interest received - operating | -31.08%16.38M | -14.23%47.39M | -0.06%23.76M | -1.80%55.25M | -20.87%23.77M | -20.43%56.26M | 18.62%30.04M | 63.69%70.7M | 123.40%25.33M | 55.13%43.19M |
| Interest paid - operating | 42.93%-9.74M | 19.82%-29.81M | 11.68%-17.07M | 16.27%-37.17M | 14.31%-19.33M | -0.97%-44.4M | -2.63%-22.55M | 15.25%-43.97M | -165.74%-21.98M | -90.79%-51.88M |
| Net cash from operations | -734.01%-95.2M | 894.15%350.94M | 80.69%-11.42M | -115.11%-44.19M | 45.33%-59.12M | 264.43%292.38M | 20.61%-108.14M | 76.01%-177.81M | 68.48%-136.21M | -81.57%-741.32M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | --3.25M | ---- | ---- | ---- | ---- | ---- | --2.04M | --2.04M | ---- |
| Restricted cash (increase) decrease | -92.17%498K | 201.58%223.82M | 165.43%6.36M | -234.39%-220.34M | -25.04%2.4M | 792.77%163.95M | -76.31%3.2M | -66.65%18.36M | -62.12%13.49M | 159.54%55.06M |
| Decrease in deposits (increase) | -922.39%-328.37M | -48.16%35.42M | 296.75%39.93M | 137.31%68.33M | 76.34%-20.29M | -174.67%-183.15M | -150.09%-85.77M | -6.16%245.27M | 130.65%171.24M | -42.16%261.36M |
| Sale of fixed assets | 281.51%2.23M | -87.10%1.05M | -91.00%584K | -77.81%8.12M | -75.79%6.49M | 90.85%36.58M | 199.58%26.81M | 107.89%19.17M | 228.25%8.95M | 21.11%9.22M |
| Purchase of fixed assets | -20.71%-31.98M | 39.44%-38.69M | 39.37%-26.49M | 29.31%-63.88M | -43.39%-43.7M | -40.36%-90.36M | -33.09%-30.47M | -104.33%-64.38M | -76.12%-22.9M | 69.84%-31.51M |
| Selling intangible assets | --107K | -92.62%786K | ---- | --10.65M | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | -19.90%-6.7M | 40.92%-10.09M | 26.85%-5.58M | 48.21%-17.08M | 55.70%-7.63M | -0.98%-32.98M | -62.69%-17.23M | 9.65%-32.66M | 53.07%-10.59M | 66.58%-36.15M |
| Sale of subsidiaries | ---832K | -44.37%1.88M | ---- | --3.39M | ---- | ---- | ---- | ---- | ---- | --308.95M |
| Acquisition of subsidiaries | ---- | ---- | ---- | --32.74M | --32.74M | ---- | ---- | -3,051.09%-12.19M | -153.67%-12.07M | -99.82%413K |
| Recovery of cash from investments | ---- | --20.65M | ---- | ---- | -33.92%168.84M | --667.84M | --255.51M | ---- | ---- | -38.74%1.2B |
| Cash on investment | 67.97%-147.21M | ---- | ---459.67M | ---- | ---- | 91.22%-15.25M | 91.98%-16.35M | 27.21%-173.57M | ---203.75M | 38.24%-238.45M |
| Other items in the investment business | -9.18%349.86M | -77.55%108.2M | 33,868.78%385.21M | 16,425.37%482.05M | -51.39%1.13M | -66.54%2.92M | -64.64%2.33M | -34.49%8.72M | -8.99%6.6M | -19.45%13.31M |
| Net cash from investment operations | -172.16%-162.4M | 13.92%346.28M | -142.63%-59.67M | -44.69%303.97M | 1.41%139.97M | 5,009.61%549.54M | 393.69%138.03M | -99.30%10.76M | -146.02%-47M | -21.71%1.55B |
| Net cash before financing | -262.38%-257.61M | 168.39%697.22M | -187.92%-71.09M | -69.14%259.78M | 170.50%80.85M | 603.97%841.92M | 116.32%29.89M | -120.78%-167.06M | 44.49%-183.2M | -48.64%804.13M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 183.93%169.55M | 3,313.88%168.48M | 1,060.91%59.72M | --4.94M | -79.56%5.14M | ---- | 130.69%25.17M | --22.8M | -93.02%10.91M |
| Refund | ---- | -1,135.65%-221.16M | ---- | 88.77%-17.9M | -165.57%-5.08M | 30.65%-159.33M | 99.17%-1.91M | -91.04%-229.74M | -743.78%-229.71M | 77.66%-120.26M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --266K | --267K | ---- |
| Dividends paid - financing | ---1.07M | ---- | ---- | ---- | ---- | -25,010.65%-73.07M | ---- | 99.92%-291K | ---291K | 25.07%-344.15M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | --43K | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---900K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | ---- | 34.75%-2.06M | ---- | 95.51%-3.16M | ---4.12M | ---70.39M | ---- | ---- | ---- | 98.90%-2.19M |
| Net cash from financing operations | -201.34%-96.64M | -73.04%-181.32M | 203.61%95.35M | 79.23%-104.79M | 18.21%-92.03M | -12.26%-504.43M | 64.81%-112.52M | 28.42%-449.34M | -191.65%-319.75M | 51.13%-627.7M |
| Effect of rate | 202.33%44.27M | -384.23%-54.72M | -191.30%-43.26M | 108.45%19.25M | 162.83%47.38M | -367.64%-227.78M | -210.77%-75.41M | -4.80%85.11M | 254.47%68.08M | 2,881.06%89.4M |
| Net Cash | -1,559.77%-354.24M | 232.85%515.9M | 317.08%24.27M | -54.07%155M | 86.47%-11.18M | 154.75%337.49M | 83.57%-82.63M | -449.38%-616.39M | -14.40%-502.96M | -37.30%176.43M |
| Begining period cash | 29.77%2.01B | 12.67%1.55B | 12.67%1.55B | 8.67%1.37B | 8.67%1.37B | -29.58%1.27B | -29.58%1.27B | 17.37%1.8B | 17.37%1.8B | 22.82%1.53B |
| Cash at the end | 11.12%1.7B | 29.77%2.01B | 8.44%1.53B | 12.67%1.55B | 27.45%1.41B | 8.67%1.37B | -18.69%1.11B | -29.58%1.27B | 30.06%1.36B | 17.37%1.8B |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.